Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
A class of drugs successfully used for treatment of metabolic bone diseases is the nitrogen-containing bisphosphonates (N-BPs), which act by inhibiting the vital enzyme, farnesyl pyrophosphate synthase (FPPS), of the mevalonate pathway. Inhibition of FPPS by N-BPs results in the intracellular accumu...
Prif Awduron: | Räikkönen, J, Taskinen, M, Dunford, J, Mönkkönen, H, Auriola, S, Mönkkönen, J |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2011
|
Eitemau Tebyg
-
Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells
gan: Räikkönen, J, et al.
Cyhoeddwyd: (2011) -
Analysis of the kinetic mechanism of inhibition of Farnesyl Pyrophosphate Synthase by nitrogen containing bisphosphonates.
gan: Dunford, J, et al.
Cyhoeddwyd: (2006) -
The mode of binding of nitrogen containing bisphosphonates in farnesyl pyrophosphate synthase
gan: Ebetino, F, et al.
Cyhoeddwyd: (2007) -
The Role of Active Site Threonine 201 in the Inhibition of Farnesyl Pyrophosphate Synthase by Nitrogen Containing Bisphosphonates
gan: Dunford, J, et al.
Cyhoeddwyd: (2008) -
Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates
gan: Dunford, J, et al.
Cyhoeddwyd: (2007)